Bloom Energy (BE) Upgraded by BMO Even as the Price Target Gets Trimmed
Nov 20, 2026 · Trading Tips
A skeptic just turned buyer on Bloom Energy (BE). BMO Capital Markets upgraded the fuel-cell maker to Outperform from Market Perform on Thursday, even as it cut its price target to $230 from $260.
The call came on the same day Anthropic went public, which put AI infrastructure back in the spotlight. Power is one of the things that buildout can't do without.
BMO analyst Ameet Thakkar said the recent pullback has left risk-reward looking much better, according to Investing.com's report on Yahoo Finance. The lower target reflects a sector-wide valuation reset, not a worse view of the company.
"We upgrade BE to Outperform and trim our target to $230/share from $260, reflecting recent multiple compression across power infrastructure." — Ameet Thakkar, Analyst, BMO Capital Markets
BMO had been cautious for months, and it laid out why. It questioned whether Bloom could execute at large scale, whether higher-cost onsite power would hold up once grid and turbine supply improves, and how much the company leans on U.S. data-center demand.
Those debates aren't settled. What changed, per 24/7 Wall St., was the price and the proof: shares pulled back, and big projects like the one for Nebius are giving BMO the execution evidence it wanted.
The stock has had a rough few weeks. It's down about 25% over the past month, yet still up roughly 103% year to date. It traded near $168 at midday Thursday.
BMO also came away from meetings with Bloom's CFO and investor-relations head more comfortable with the commercial structure. That includes contractual protections, milestone-based customer payments, project financing and the ability to scale manufacturing.
The business itself is growing fast. Third-quarter revenue rose 138.1% year over year to $1.24 billion, and management raised full-year 2026 guidance for the third time to $4.4 billion to $4.6 billion in revenue and $3.10 to $3.40 in adjusted EPS.
On the October 22 earnings call, founder and CEO K. R. Sridhar told analysts, "We have our servers ready for the 300 megawatts. We will not be the bottleneck." That's the promise Nebius-scale deployments are now being measured against.
BMO's 2027 revenue estimate of $7.88 billion sits above consensus, and the firm says its backlog-conversion work supports it. The 2030 framework assumes about 7.5 gigawatts of manufacturing capacity.
The stock-specific takeaway: this is a bet on execution, not a cheap multiple. Only Bloom has turned data-center demand into a profitable business so far. FuelCell Energy (FCEL) and Plug Power (PLUG) are still working toward profitability, and Plug is down 46% this year.
That gap helps explain why Bloom keeps its premium. It also means the stock is priced for success, which leaves little room for slip-ups.
Now the counterpoint. BMO itself flagged that the near-term risk is the company's initial guidance. A first guide that falls short could disappoint a market used to three straight raises.
The longer-term bar is higher still. The valuation case needs Bloom to expand beyond U.S. data centers into international markets, commercial and industrial customers and possibly utility-scale power.
And the macro tape isn't helping. Bloom reversed lower Thursday as the Nasdaq sold off, Investor's Business Daily reported, so a good analyst call didn't protect it from a rough market day.
For investors, the question is how to treat an upgrade that comes with a lower target. The $230 level is about 37% above Thursday's price, but it's a moving target if power-infrastructure multiples keep compressing.
What to watch: new multi-hundred-megawatt orders, any update on Nebius deployment timing, and how quickly backlog turns into revenue. Any of those would back up BMO's thesis. A guidance disappointment in the next report would hurt it.
If you already own the stock, the upgrade doesn't change the risk profile much. If you're looking to start a position, scaling in over several weeks fits a name that dropped about 18% in five sessions before this call.
Bottom line: BMO likes Bloom more at a lower price, and the next few quarters will show whether the execution lives up to the story.